GlassScriptPhysician profile
Jennifer Lesic
NPI 1982690079
$672.45
in general payments reported to CMS, 2019-2025
12 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $59.21 · 2021: $80.87 · 2022: $98.21 · 2023: $143 · 2024: $63.87 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $259.66 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $129.99 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $46.94 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $45.67 | 2020-2025 | |
| Ironshore Pharmaceuticals INC. | $24.07 | 2023 | Jornay Pm |
| Shire North American Group INC | $23.46 | 2019 | |
| Seqirus USA INC | $23.13 | 2024 | Flucelvax |
| Biomarin Pharmaceutical INC. | $22.91 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $19.81 | 2025 | Neffy |
| Cranial Technologies, INC | $17.19 | 2025 | Doc Band |
| Corium, LLC | $11.71 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lesic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.